Dr. Hamid Reza Ahmadkhaniha

Male, Born: 1965, Tehran | Married, 1 child | Work at: Iran University of Medical Sciences

I am an associate professor specializing in psychiatry with a focus on substance abuse treatment, based at Iran University of Medical Science and Iran Psychiatric Hospital. I have extensive experience in both clinical practice and academic roles. In my clinical role, I develop and implement innovative treatment strategies for patients with substance abuse disorders, providing both care and empowerment. Academically, I teach and mentor future medical professionals, integrating practical experience with theoretical learning. My scholarly contributions include 37 articles on substance abuse treatment, enhancing understanding and treatment approaches in the field. My work is driven by a commitment to improve psychiatric care and a belief in the resilience and recovery potential of individuals.

ACADEMIC PROFILE

• Academic Position: Associate professor
• Academic Degree: Specialization in psychiatry
• University: Iran University of Medical Science
• Hospital: Iran psychiatric Hospital
• Research Center: Research Center for Addiction and Risky Behaviors
• ORCID: 0000-0003-0023-3544
• ResearchGate Profile: https://www.researchgate.net/profile/Hamid-Ahmadkhaniha
• Scopus Profile: https://www.scopus.com/authid/detail.uri?authorId=21833498100
• Google Scholar Profile: https://scholar.google.com/citations?hl=en&user=HCVvzVMAAAAJ
• PubMed Articles: https://pubmed.ncbi.nlm.nih.gov/?term=hamidreza+ahmadkhaniha%5BAuthor%5D&sort=
• Web of science Article: https://www.webofscience.com/wos/author/record/N-5867-2018

 

EDUCATIONS

• 1988-1995: Medical Doctorate, Ahvaz University of Medical Sciences
• 1998-2001: Psychiatry Specialist, Iran University of Medical Sciences
• 2001: Board Certification in Psychiatry

 

SKILLS

Associate Professor of Psychiatry:

• Curriculum development and instruction
• Academic research and publishing
• Mentorship and student supervision
• Presentation and public speaking
• Leadership and administration in academia

 

Psychiatrist Specializing in Substance Abuse Treatment:

• Clinical assessment and diagnosis
• Individualized treatment planning
• Pharmacotherapy management
• Crisis intervention and management

 

Researcher in Psychiatric Disorders and Substance Abuse:

• Study design and methodology
• Data collection and analysis
• Literature review and synthesis
• Scientific writing and publication

 

PROFESSIONAL MEMBERSHIPS

• 2002-2012: Deputy of Tehran Institute of Psychiatry, Iran University of Medical Sciences
• 2007-present: Faculty Member, Department of Psychiatry, Iran University of Medical Sciences
• 2015-present: Deputy of Research Center for Addiction and Risky Behaviors
• 2002-present: Reviewer in reputable journals

 

RESEARCH ACTIVITIES (GRANTS RECEIVED)

• Title: The effect of web-based interventions on the relapse rate of Methamphetamine use disorder at Iran psychiatric hospital. Grant number: 22078
• Title: Correlation of CRP serum level with severity and disease relapse in psychotic schizophrenic, acute psychotic manic and methamphetamine induced psychotic patients. Grant number: 3152
• Title: A Qualitative Study on the Psychological Needs of Wives of Drug Users. Grant number: 7687
• Title: Mental health and risky behaviors in children of substance abusers in comparison with non-substance abusers. Grant number: 7689
• Title: Comparison of blood level of vitamin D, calcium, phosphorus and PTH in patients with schizophrenia, manic episode with psychotic features and methamphetamine-induced psychotic disorder with control group. Grant number: 7909
• Title: Evaluation of mental health in patients who were admitted in Iran psychiatric hospital. Grant number: 8366
• Title: Comparison of positive signs and negative signs with schizophrenic patients and prolonged methamphetamine induced psychotic disorder. Grant number: 8374
• Title: Comparison of Predisposing Factors in Patients with Prolonged Methamphetamine-Induced Psychotic Disorder and Schizophrenia. Grant number: 9131

 

PUBLISHED ARTICLES

• Arya S, Kamyab A, Sanatkar SA, Pourmehdiardebili M, Ebrahimi A, Kamyab P, Alavi K, Zarei Z, Ahmadkhaniha HR. Evaluating the association of vitamin D3, parathyroid hormone, and C-reactive protein serum levels in patients with an acute psychotic episode: a cross-sectional study in tertiary centre in Iran. BMC psychiatry. 2023 Oct 6;23(1):724.
• Gharahi E, Soraya S, Ahmadkhaniha H, Sadeghi B, Haghshenas M, Bozorgmehr A. Cognitive network reconstruction in individuals who use opioids compared to those who do not: topological analysis of cognitive function through graph model and centrality measures. Frontiers in Psychiatry. 2023 Jan 4;13:999199.
• Oladikalarijani M, Shabani A, Soraya S, Ahmadkhaniha H. Comorbidities of Major Depressive Disorder and Bipolar Disorders in Patients with Substance Use Disorder in Iran Psychiatric Hospital: A Cross-sectional Study. Medical Journal of the Islamic Republic of Iran. 2023;37.
• Kamalzadeh L, Shariati B, Keshavarz-Akhlaghi AA, Jalali Nadoushan AH, Asadi S, Seify-Moghadam N, Mirfazeli FS, Kashaninasab F, Ghadirivasfi M, Shirazi E, Shabani A. World Psychiatric Association (WPA) Early Career Psychiatrist Exchange Program in Iran: Faculty Perspectives. Academic Psychiatry. 2023 Aug;47(4):452-4.
• Eghdami S, Ahmadkhaniha HR, Baradaran HR, Hirbod-Mobarakeh A. Ecological momentary interventions for smoking cessation: a systematic review and meta-analysis. Social Psychiatry and Psychiatric Epidemiology. 2023 Oct;58(10):1431-45.
• Soraya S, Rashedi V, Saeidi M, Hashemi P, Hadi F, Ahmadkhaniha H, Shalbafan M. Comparison of online sexual activity among Iranian individuals with and without substance use disorder: a case-control study. Frontiers in Psychiatry. 2022 Jul 22;13:889528.
• Ahmadkhaniha H, Ayazi N, Alavi K, Najjarzadehgan M, Hadi F. The comparison between positive and negative symptoms severity in prolonged methamphetamineinduced psychotic disorder and schizophrenia. Basic and clinical neuroscience. 2022 May;13(3):325.
• Asadi M, Rashedi V, Khademoreza N, Seddigh R, Keshavarz-Akhlaghi AA, Ahmadkhaniha H, Rezvaniardestani SM, Lotfi A, Shalbafan M. Medication adherence and drug attitude amongst male patients with the methamphetamine-induced psychotic disorder after discharge: a three months follow up study. Journal of Psychoactive Drugs. 2022 Jan 1;54(1):18-24.
• Soraya S, Haghshenas M, Ahmadkhaniha H, Azarnik S, MansourKiaei H, Rassouli S, Seddigh R. Needs of Spouses of Patients with Substance Use Disorder: A Qualitative Study. Journal of Iranian Medical Council. 2021 Apr 1;4(2):86-92.
• Effatpanah H, Effatpanah M, Mohammadi MJ, Geravandi S, Ghadami M, Ahmadkhaniha H, Djavid GE, Arabgol F. Determination of association between the polymorphism in exon 3 of dopamine receptor gene type 4 with attention deficit-hyperactivity disorder. Clinical Epidemiology and Global Health. 2020 Mar 1;8(1):290-4.
• Hadizadeh H, Salehi M, Bozorgnia AR, Ahmadkhaniha HR. Lower folate levels in methamphetamine-induced psychosis: A cross-sectional study. Drug and Alcohol Dependence. 2020 Feb 1;207:107682.
• Soheilipour F, Shiri S, Ahmadkhaniha HR, Abdollahi E, Hosseini-Baharanchi FS. Risk factors for attention-deficit/hyperactivity disorder: a case-control study in 5 to 12 years old children. Medicine and Pharmacy Reports. 2020 Apr;93(2):175.
• Shalbafan M, Rashedi V, Seddigh R, Najarzadegan M, Azarpajouh T, Ahmadkhaniha H, Kamalzadeh L. Validity and reliability of the Persian version of “drug-related knowledge and attitude questionnaire” among Iranian medical students. Journal of Addictive Diseases. 2020 Jul 13;38(4):489-94.
• Naeini AA, Ranjbar H, Mohammadsadeghi H, Alavi K, Ahmadkhaniha H, Rasoulian M. Assessment of psychiatrists’ approaches regarding disclosure of psychiatric disorders to their patients: a qualitative study. Medical journal of the Islamic Republic of Iran. 2020;34:82.
• Motavaselian M, Ghanbari Jolfaei A, Ghadiri Vasfi M, Ahmadkhaniha HR, Eftekhar Ardebili M, Alavi K, Soltani Ramezanzadeh M. Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on the Drug Use Craving in Patients with Methamphetamine Dependency During Withdrawal Phase: A Sham Controlled Randomized Clinical Trial. Journal of Iranian Medical Council. 2020 Apr 1;3(2):89- 98.
• Shalbafan M, Najarzadegan M, Soraya S, Rashedi V, Najafian R, Ahmadkhaniha H, Seddigh R, Hassanzadeh M, Saeedi V, Kamalzadeh L. Validity and reliability of the Persian version of Internet Sex Screening Test in Iranian medical students. Sexual Addiction & Compulsivity. 2019 Oct 2;26(3-4):361-70.
• Ahmadkhaniha HR, Alavi K, Hadi F. Prolonged methamphetamine-induced psychosis: Difference with schizophrenia. Acta Medica Iranica. 2019 Nov 25.
• Ahmadkhaniha HR, Alavi K, Rouhi E, Najarzadegan MR. Mental health assessment in patients admitted to iran psychiatric hospital with a diagnosis of psychosis due to 2-5 years of methamphetamine use. International Journal of High Risk Behaviors and Addiction. 2018 Jun 30;7(2).
• Suleimani Mohammadi F, Rahimi Foroushani A, Rokni M, Farahmand M, Ahmadi Kia K, Shadab A, Ahmadkhaniha H, Yavarian J. Comparative study of cytomegalovirus antibody and viral load in schizophrenia and bipolar patients. Tehran University of Medical Sciences Journal. 2017 Feb 10;74(11):778-82.
• Shatizadeh-Malekshahi S, Ahmadkhaniha HR, Kiani SJ, Nejati A, Janani L, Yavarian J. No molecular evidence of Borna disease virus among schizophrenia and bipolar disorder patients in Iran. Iranian Journal of Microbiology. 2017 Apr;9(2):112.
• Malakouti SK, Nojomi M, Ahmadkhaniha HR, Hosseini M, Fallah MY, Khoshalani MM. Integration of suicide prevention program into primary health care network: a field clinical trial in Iran. Medical journal of the Islamic Republic of Iran. 2015;29:208.
• Yavarian J, Shatizadeh Malekshahi S, Yavarian R, Yazdani S, Janani L, Shafiei Jandaghi NZ, Kiani SJ, Ahamadkhaniha H. Type specific Real time PCR for detection of human herpes virus 6 in schizophrenia and bipolar patients: a case control study. BMC psychiatry. 2015 Dec;15:1-6.
• Ahmadkhaniha HR, Bani-Hashem S, Ahmadzad-Asl M. Depot typical antipsychotics versus oral atypical antipsychotics in relapse rate among patients with schizophrenia: A five-year historical Cohort study. Iranian Journal of Psychiatry and Behavioral Sciences. 2014;8(1):66.
• Abdolmaleky HM, Nohesara S, Ghadirivasfi M, Lambert AW, Ahmadkhaniha H, Ozturk S, Wong CK, Shafa R, Mostafavi A, Thiagalingam S. DNA hypermethylation of serotonin transporter gene promoter in drug naive patients with schizophrenia. Schizophrenia research. 2014 Feb 1;152(2-3):373-80.
• Pornour M, Ahangari G, Hejazi SH, Ahmadkhaniha HR, Akbari ME. Dopamine receptor gene (DRD1-DRD5) expression changes as stress factors associated with breast cancer. Asian Pacific Journal of Cancer Prevention. 2015;15(23):10339-43.
• Hejazi SH, Ahangari G, Pornour M, Deezagi A, Aminzadeh S, Ahmadkhaniha HR, Akbari ME. Evaluation of gene expression changes of serotonin receptors, 5-HT3AR and 5-HT2AR as main stress factors in breast cancer patients. Asian Pacific Journal of Cancer Prevention. 2014;15(11):4455-8.
• Ahmadkhaniha H, Mostafavi HA, Nojoomi M, Parvizi-Emran B. Age specific prevalence of metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics and control group. HealthMED. 2012 Jan 1;6(11):3680-4.
• Nohesara S, Ghadirivasfi M, Mostafavi S, Eskandari MR, Ahmadkhaniha H, Thiagalingam S, Abdolmaleky HM. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. Journal of psychiatric research. 2011 Nov 1;45(11):1432-8.
• Ghadirivasfi M, Nohesara S, Ahmadkhaniha HR, Eskandari MR, Mostafavi S, Thiagalingam S, Abdolmaleky HM. Hypomethylation of the serotonin receptor type‐ 2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2011 Jul;156(5):536-45.
• Naserbakht M, Ahmadkhaniha HR, Mokri B, Smith CL. Advanced paternal age is a risk factor for schizophrenia in Iranians. Annals of general psychiatry. 2011 Dec;10:1- 6.
• Shariati GR, Ahangari G, Hossein-nezhad A, Asadi SM, Pooyafard F, Ahmadkhaniha HR. Expression changes of serotonin receptor gene subtype 5HT3a in peripheral blood mononuclear cells from schizophrenic patients treated with haloperidol and Olanzapin. Iranian Journal of Allergy, Asthma and Immunology. 2009:135-9.
• Ahangari G, Shariati GH, Asadi MR, Ostadali MR, Ahmadkhaniha HR. Novel Mutation Detection of Regulatory Molecule Dopamine Gene Receptors (D1–D5) Encoding Analysis on Human Peripheral Blood Lymphocytes in Schizophrenia Patients. European Journal of Inflammation. 2009 Sep;7(3):145-52.
• Shariati GH, Ahangari G, Asadi MR, Poyafard F, Ahmadkhaniha HR. Dopamine receptor gene expression changes in peripheral blood mononuclear cells from schizophrenic patients treated with haloperidol and olanzapine. European Journal of Inflammation. 2009 May;7(2):71-6.
• Ghahari SH, Bolhari J, ATEF VM, Ahmadkhaniha HR, Panaghi L, Yousefi H. Prevalence of spouse abuse, and evaluation of mental health status in female victims of spousal violence in Tehran.
• Abdolmaleky HM, Ahmadkhaniha HR, Nohesara S, Smith CL. Epigenetic and genetic aberrations of the brain dopaminergic system in schizophrenia and bipolar disorder: achievements and prospective. Iranian Journal of Psychiatry and Behavioral Sciences. 2008 Jan 31;2(1):4-13.
• Ahmadkhaniha H, Tayebi A. A case report of neuroleptic malignant syndrome induced by clozapine is neuroleptic malignant syndrome diagnostic criteria adequately sensitive to identify diverse features of the syndrome?.
• Ahmadkhaniha HR, Shariat SV, Torkaman-Nejad S, Moghadam MM. The frequency of sexual abuse and depression in a sample of street children of one of deprived districts of Tehran. Journal of child sexual abuse. 2007 Aug 29;16(4):23-35.

 

BOOKS

• Educational/training book of women mental health & social skills for general proctioner, 2003. Mahdavi Hazaveh, N. Iranpoor, C. Yassami, MT. Bina, M. Khazaeli, A. Davari, R. Shirazi, E. Arabgol, F. Samimy, S.M. Ahmadkhaniha, HR. Chimeh, N. Shadloui, F. Lavasani, F. Yazdi, BA.
• Educational/training book of women mental health & social skills for Psychiatrist, 2003. Mahdavi Hazaveh, N. Iranpoor, C. Yassami, MT. Bina, M. Khazaeli, A. Davari, R. Shirazi, E. Arabgol, F. Samimy, S.M. Ahmadkhaniha, HR. Chimeh, N. Shadloui, F. Lavasani, F. Yazdi, BA.
• Educational/ training book of women mental health & social skills for For mental health worker, 2003. Mahdavi Hazaveh, N. Iranpoor, C. Yassami, MT. Bina, M. Khazaeli, A. Davari, R. Shirazi, E. Arabgol, F. Samimy, S.M. Ahmadkhaniha, HR. Chimeh, N. Shadloui, F. Lavasani, F. Yazdi, BA.
• Educational/training book of women mental health & social skills for For school consultant, 2003. Mahdavi Hazaveh, N. Iranpoor, C. Yassami, MT. Bina, M. Khazaeli, A. Davari, R. Shirazi, E. Arabgol, F. Samimy, S.M. Ahmadkhaniha, HR. Chimeh, N. Shadloui, F. Lavasani, F. Yazdi, BA.
• Textbook of clinical psychiatry& behavioral sciences. By psychiatric professors of Iran University of Medical Sciences.
• Textbook of clinical psychiatry& behavioral sciences. By psychiatric professors of Iran University of Medical Sciences. Second edition.
• Textbook of Sleep medicine.1393

 

REFERENCES

• [Hamid Reza Ahmadkhaniha], [Department of Psychiatry, School of Medicine], [Dr_ahmadkhaniha@yahoo.com], [0989123546015]
• [Hamid Reza Ahmadkhaniha], [Research Center for Addiction and Risky Behaviors], [Dr_ahmadkhaniha@yahoo.com], [0989123546015]

 

Languages:

• English: Fluent
• Persian: Native